Will Fortis undergo a Name Change? IHH to decide Medical Dialogues Bureau16 Nov 2018 2:47 PM IST“Our most optimistic target is that by the middle of December we will put up the offer and we are cautiously optimistic that by end of December we can...
Lupin gets USFDA nod for Decitabine- Myelodysplastic Syndrome drug Medical Dialogues Bureau16 Nov 2018 11:30 AM ISTMumbai: Pharma major Lupin has recently announced that it has received approval for its Decitabine for Injection, 50 mg/vial, Single-Dose Vial from...
AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore Medical Dialogues Bureau16 Nov 2018 10:30 AM ISTNew Delhi: Drug firm AstraZeneca Pharma India has recently reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended...
Make in Odisha: government launches Rs 2750 Crore investment in Healthcare Medical Dialogues Bureau16 Nov 2018 10:00 AM ISTNew Delhi: Odisha government has launched the Vision-2025 health care at the Make in Odisha Conclave 2018, the flagship biennial global investors'...
Merck cancer drug Keytruda succeeds in late-stage trial Medical Dialogues Bureau16 Nov 2018 9:45 AM ISTNew Delhi: U.S Drugmaker Merck & Co has recently announced that blockbuster cancer drug keytruda met the main goal of a late-stage trial, of...
Walmart, Home Depot adopt health insurer tactic in drug copay battle Medical Dialogues Bureau16 Nov 2018 9:00 AM ISTNEW YORK: Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using...
Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court Medical Dialogues Bureau15 Nov 2018 11:42 AM ISTThe expiry of the basic patent on Lyrica five years ago had allowed generic drugmakers to launch cut-price versions of Pfizer's medicine, which...
Suven Life Sciences gets Product Patents in Australia and Hong Kong Medical Dialogues Bureau15 Nov 2018 11:30 AM ISTHyderabad: Suven Life Science Ltd has recently announced that the grant of one product patent from Australia and one product patent from Hong Kong...
Zydus gets USFDA nod for Arsenic Trioxide Injection Medical Dialogues Bureau15 Nov 2018 11:05 AM ISTNew Delhi: Zydus Cadila has received the final approval from the USFDA to market Arsenic Trioxide Injection, 10 mg/10 mL (1 mg/mL) single-dose vial...
Cipla's subsidiary to acquire US-based Avenue Therapeutics for Rs 156 Crore Medical Dialogues Bureau15 Nov 2018 9:55 AM ISTNew Delhi: Drug major Cipla has recently announced its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire...
Aurobindo Pharma shares fall 3% after Q2 earnings Medical Dialogues Bureau15 Nov 2018 9:45 AM ISTNew Delhi: Shares of Aurobindo Pharma has recently fallen almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit...
Lupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in US Medical Dialogues Bureau14 Nov 2018 3:00 PM ISTNew Delhi: Drug giant Lupin has recently launched the generic Atovaquone oral suspension USP, which is used for the prevention and treatment of...
